but pphm management thinks communicating with shareholders is a sign of weakness and the FDA looks at it unfavorably.....I'm sure Chris thinks would say these people must be very desperate.
Interesting. Not far off our plight if you compare charts the last 20 years. Except, they have started up in the last year after hitting bottom in line with their move to phase III. They have a market cap of 107M vs. our 42M and they have approx 260M shares O/S vs, our 1--M shares.